A supply of Alaris infusion pumps, worth approximately 1.8 million dollars, was seized by United States Marshals. The seizure involved several models of Alaris infusion pumps, and took place at the company’s manufacturing plant in San Diego, California. A design defect called “key bounce” could cause the infusion pumps to deliver an over-infusion of medication, which may result in injury or death. Despite being warned by the FDA in 1998 and 1999, Alaris failed to correct manufacturing violations. The company has suggested actions to minimize the likelihood of key errors and promised a permanent correction of the problem for customers, once such a correction is available.
Comments are closed.